The Challenge
Amgen, a global bio-pharmaceutical company, operates to promote healthy ageing and improve the lives of those who suffer from serious diseases. The world’s population of people over 60 is growing; already nearing 1bn. United Nations predicts that by 2050 this figure will reach 2.1bn, with around half of these living in Asia. In such an environment, one of the biggest challenges for Amgen is to create awareness of some of the leading diseases in Asia. There are two focus areas: Cardiovascular disease (CVD) and Osteoporosis (OP). CVD is the leading cause of death in the world, and one...